Granted Patent B2

US 9,063,066 · App. 13/317,341 · Granted Jun 23, 2015

Abstract

Claims (15)

1. A method to quantify biomarkers, comprising providing a sample comprising a biomarker, the biomarker comprising one or more chemicals that are related to a physiological condition; using an X-ray fluorescence spectrometer to perform an X-ray fluorescence analysis on the sample to obtain spectral features derived from the biomarker; and quantifying the X-ray fluorescence signal of the biomarker; wherein the X-ray fluorescence spectrometer irradiates the sample with polychromatic X-rays, and wherein the sample is exposed to a solution that is substantially free of at least one element selected from the list of phosphorus and sulfur.

2. The method of claim 1 , wherein the X-ray fluorescence spectrometer comprises an X-ray tube that uses less than 20 kilowatts of power.

3. The method of claim 1 , wherein the sample is disposed on or in a sample holder, and the sample holder comprises at least one chemical element which is not present in the sample.

4. The method of claim 1 , wherein the sample is fractionated prior to performing of the X-ray fluorescence analysis.

5. A method to diagnose abnormal conditions, comprising providing one or more clinical samples, the one or more clinical samples comprising a biomarker; using an X-ray fluorescence spectrometer to perform an X-ray fluorescence analysis on at least one of the one or more clinical samples to obtain spectral features derived from at least one biomarker; and quantifying the X-ray fluorescence signal of the biomarker, wherein the X-ray fluorescence spectrometer irradiates the sample with polychromatic X-rays, and wherein the one or more clinical samples are exposed to a solution that is substantially free of at least one element selected from the list of phosphorus and sulfur.

6. The method of claim 5 , wherein the one or more clinical samples are disposed on or in a sample holder, and the sample holder comprises at least one chemical element which is not present in the sample.

7. The method of claim 5 , further comprising the step of obtaining data concerning the at least one of the one or more clinical samples using at least one other test.

8. The method of claim 7 , further comprising the step of comparing the spectral features derived from the biomarker to data obtained from the at least one other test.

9. The method of claim 5 , wherein the sample is fractionated prior to the performing of the X-ray fluorescence analysis.

10. The method of claim 5 , further comprising the step of performing a diagnosis.

11. A method to identify one or more abnormal portions of a sample, comprising providing a clinical sample disposed on or in a sample holder, the clinical sample comprising normal and abnormal portions; providing an X-ray fluorescence spectrometer, the X-ray fluorescence spectrometer comprising a X-ray excitation source; using the X-ray fluorescence spectrometer to perform an X-ray fluorescence analysis on the clinical sample to obtain spectral features derived from at least one biomarker; and using spectral features derived from the biomarker to determine whether at least one portion of the sample is normal or abnormal, wherein

the X-ray fluorescence is performed using excitation of the sample with polychromatic X-rays, and wherein the X-ray fluorescence analysis comprises multiple X-ray fluorescence analyses obtained wherein the sample is disposed at at least two different angles relative to the excitation source.

12. The method of claim 11 , wherein the X-ray excitation source is an X-ray tube that uses less than 20 kilowatts of power.

13. The method of claim 11 , where the sample is exposed to a solution that is substantially free of at least one element selected from the list of phosphorous and sulfur.

14. The method of claim 11 , further comprising the step of constructing a tomogram.

Assignments (13)